Preclinical and experimental evidence of salvianolic acid B in the treatment of neurological diseases

Preclinical and experimental evidence of salvianolic acid B in the treatment of neurological diseases

BackgroundNeurological diseases such as stroke and Alzheimer’s disease pose increasing challenges to global public health. Salvianolic Acid B (SalB), a major active component of Salvia miltiorrhiza, has garnered attention due to its anti-inflammatory, antioxidant, neuroprotective, and pro-angiogenic...

Full description

Saved in:
Bibliographic Details
Main Authors: Shijun Bi, Shibing Liu, Kunyuan Zhu, Dandan Gao, Ligang Chen, Chunyong Yu, Guobiao Liang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Pharmacology
Subjects:
salvianolic acid B
neurological diseases
anti-inflammatory
anti-oxidative stress
neuroprotective
angiogenesis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1606146/full
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1606146/full

Similar Items